145 related articles for article (PubMed ID: 7585052)
1. Assessing animal models of AIDS.
Stott J; Almond N
Nat Med; 1995 Apr; 1(4):295-7. PubMed ID: 7585052
[No Abstract] [Full Text] [Related]
2. The quest for vaccines against AIDS: progress and challenges. An overview.
Schild GC; Stott EJ
Vaccine; 1991 Nov; 9(11):779-81. PubMed ID: 1759497
[No Abstract] [Full Text] [Related]
3. Progress with HIV vaccines.
Biberfeld G; Emini EA
AIDS; 1991; 5 Suppl 2():S129-33. PubMed ID: 1845044
[No Abstract] [Full Text] [Related]
4. Immunization for long-term protection against AIDS using the macaque model.
Kumar A; Narayan O
Virology; 2001 Jun; 285(1):1-5. PubMed ID: 11414799
[No Abstract] [Full Text] [Related]
5. Challenges and strategies for AIDS vaccine development.
Oxford JS; Frezza P; Race E
Vaccine; 1993; 11(6):612-4. PubMed ID: 8100664
[TBL] [Abstract][Full Text] [Related]
6. The status of HIV/AIDS vaccines--1993.
Weber J
Ther Immunol; 1994 Apr; 1(2):95-100. PubMed ID: 7584488
[No Abstract] [Full Text] [Related]
7. AIDS vaccines: is older better?
Cohen J
Science; 1992 Dec; 258(5090):1880-1. PubMed ID: 1470911
[No Abstract] [Full Text] [Related]
8. Modern vaccines. Human immunodeficiency virus and AIDS: challenges and progress.
Schild GC; Minor PD
Lancet; 1990 May; 335(8697):1081-4. PubMed ID: 1970381
[No Abstract] [Full Text] [Related]
9. Animal models for HIV infection and AIDS.
Bull Pan Am Health Organ; 1989; 23(1-2):215-34. PubMed ID: 2541843
[No Abstract] [Full Text] [Related]
10. Attenuated vaccines for AIDS.
Victorino RM; Sousa AE
Lancet; 1995 Jul; 346(8968):179. PubMed ID: 7603240
[No Abstract] [Full Text] [Related]
11. Protection against human immunodeficiency virus type 2 and simian immunodeficiency virus in macaques vaccinated against human immunodeficiency virus type 2.
Biberfeld G; Thorstensson R; Putkonen P
AIDS Res Hum Retroviruses; 1996 Mar; 12(5):443-6. PubMed ID: 8882330
[No Abstract] [Full Text] [Related]
12. Protection against chronic infection and AIDS by an HIV envelope peptide-cocktail vaccine in a pathogenic SHIV-rhesus model.
Nehete PN; Chitta S; Hossain MM; Hill L; Bernacky BJ; Baze W; Arlinghaus RB; Sastry KJ
Vaccine; 2001 Dec; 20(5-6):813-25. PubMed ID: 11738745
[TBL] [Abstract][Full Text] [Related]
13. Primate models of AIDS.
Joag SV
Microbes Infect; 2000 Feb; 2(2):223-9. PubMed ID: 10742694
[TBL] [Abstract][Full Text] [Related]
14. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
15. AIDS vaccine development in primate models.
Almond NM; Heeney JL
AIDS; 1998; 12 Suppl A():S133-40. PubMed ID: 9632994
[No Abstract] [Full Text] [Related]
16. Present status of human HIV vaccine development.
Calarota SA; Weiner DB
AIDS; 2003; 17 Suppl 4():S73-84. PubMed ID: 15080183
[No Abstract] [Full Text] [Related]
17. [Live attenuated viruses: a new strategy for vaccination against AIDS].
Molina JM
Pathol Biol (Paris); 1993 Jun; 41(6):513-4. PubMed ID: 8247628
[No Abstract] [Full Text] [Related]
18. AIDS vaccines show promise in primates.
Clin Infect Dis; 2001 Oct; 33(7):i-ii. PubMed ID: 11592258
[No Abstract] [Full Text] [Related]
19. HIV vaccine design: insights from live attenuated SIV vaccines.
Koff WC; Johnson PR; Watkins DI; Burton DR; Lifson JD; Hasenkrug KJ; McDermott AB; Schultz A; Zamb TJ; Boyle R; Desrosiers RC
Nat Immunol; 2006 Jan; 7(1):19-23. PubMed ID: 16357854
[TBL] [Abstract][Full Text] [Related]
20. Developments in preclinical AIDS vaccine efficacy models.
Bogers WM; Cheng-Mayer C; Montelaro RC
AIDS; 2000; 14 Suppl 3():S141-51. PubMed ID: 11086857
[No Abstract] [Full Text] [Related]
[Next] [New Search]
